Clinical trial
Safety and Efficacy Analysis of FRED® Embolic Device in Aneurysm Treatment
NCT02921698 is registered in ClinicalTrials.gov with Microvention-Terumo, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Analysis of FRED® Embolic Device in Aneurysm Treatment
- Lead sponsor
- Microvention-Terumo, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- December 31, 2017
- Enrollment
- 100 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
intracranial aneurysms